Anti-IL-20 monoclonal antibody (mAb) 7E significantly improves the symptoms of arthritis through reducing thickness and swelling of hind-paw, suppressing bone destruction, and inhibiting the production of proinflammatory cytokines in synovial tissue. This evidence concerns the gene IL20 and Arthritis.